SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-087893
Filing Date
2023-11-16
Accepted
2023-11-16 15:22:13
Documents
13
Period of Report
2023-11-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea188617-8k_immucell.htm   iXBRL 8-K 27952
2 THIRD AMENDMENT OF INDENTURE OF LEASE FOR PREMISES LOCATED IN PORTLAND, MAINE BE ea188617ex10-1_immucell.htm EX-10.1 21794
  Complete submission text file 0001213900-23-087893.txt   224415

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE iccc-20231114.xsd EX-101.SCH 3015
4 XBRL LABEL FILE iccc-20231114_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE iccc-20231114_pre.xml EX-101.PRE 22359
7 EXTRACTED XBRL INSTANCE DOCUMENT ea188617-8k_immucell_htm.xml XML 3206
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 231414340
SIC: 2835 In Vitro & In Vivo Diagnostic Substances